Osimertinib for NSCLC With Uncommon EGFR Mutations

Israel

Suspended

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Carcinoma, Non-Small-Cell Lung · Genes, erbB-1

Locations

Sheba Medical Centre, Ramat Gan, Israel

View source on ClinicalTrials.gov